| Product Code: ETC7656867 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market - Industry Life Cycle |
3.4 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market - Porter's Five Forces |
3.5 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume Share, By Symptoms, 2021 & 2031F |
3.6 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.8 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neonatal hypoxic-ischemic encephalopathy in Israel |
4.2.2 Technological advancements in neonatal care and treatment options |
4.2.3 Growing awareness about early diagnosis and intervention for neonatal brain injuries |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure and resources in some regions of Israel |
4.3.2 Stringent regulatory requirements for approval of neonatal hypoxic-ischemic encephalopathy treatments |
4.3.3 High costs associated with advanced treatment options |
5 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Trends |
6 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market, By Types |
6.1 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market, By Symptoms |
6.1.1 Overview and Analysis |
6.1.2 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Symptoms, 2021- 2031F |
6.1.3 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Breathing Problems, 2021- 2031F |
6.1.4 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Feeding Problems, 2021- 2031F |
6.1.5 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Missing Reflexes, 2021- 2031F |
6.1.6 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Seizures, 2021- 2031F |
6.1.7 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Low Apgar Scores, 2021- 2031F |
6.1.8 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Low or High Muscle Tone, 2021- 2031F |
6.2 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Therapeutic hypothermia, 2021- 2031F |
6.2.3 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Drugs, 2021- 2031F |
6.2.4 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Other, 2021- 2031F |
6.3 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market, By Mode of Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.3 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.4 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market, By End-User |
6.5.1 Overview and Analysis |
6.5.2 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Import-Export Trade Statistics |
7.1 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Export to Major Countries |
7.2 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Imports from Major Countries |
8 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Key Performance Indicators |
8.1 Neonatal hypoxic-ischemic encephalopathy screening rates in Israel |
8.2 Adoption rates of innovative treatment modalities for neonatal brain injuries |
8.3 Research and development investment in new therapies for neonatal hypoxic-ischemic encephalopathy |
9 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market - Opportunity Assessment |
9.1 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Opportunity Assessment, By Symptoms, 2021 & 2031F |
9.2 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.4 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market - Competitive Landscape |
10.1 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Revenue Share, By Companies, 2024 |
10.2 Israel Neonatal Hypoxic-Ischemic Encephalopathy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here